Introduction: Toxoplasma gondii (T. gondii) is an obligate intracellular protozoan that infects most warm-blooded vertebrates. Because of the immunodeficiency in hemodialysis patients, these individuals are at higher risk for reactivating chronic toxoplasmosis; therefore, a diagnosis of early and definitive in these individuals is highly desirable. Thus, the aim of this study is to investigate seroepidemiology of toxoplasmosis in hemodialysis patients of Ahvaz, southwest of Iran during 2015-2016. Methods: This is a cross-sectional study. A total of 160 participants, 80 hemodialysis patients (test group) and 80 healthy persons (control group) were randomly selected. IgG and IgM against T. gondii was measured by CLIA (Chemiluminescence) and ELISA (Enzyme-linked immunosorbent assay) tests. To analyze the data from Chi-square test, and SPSS statistical software of version 21 was used. Result: In hemodialysis patients, 35 (43.8%) and 25 (31.3%) were positive for the antibody of IgG by ELISA and CLIA, respectively. In healthy individuals, a positive result of 22 (27.5%) and 13 (16.3%) were obtained by ELISA and CLIA, respectively. In hemodialysis patients, 5 (6.3%) and 4 (5%) was positive by ELISA and by CLIA, respectively. In healthy individuals, a positive of 4 (5%) were obtained by ELISA and CLIA. The antibodies of IgG in hemodialysis patients was significantly higher than healthy individuals by ELISA and CLIA (P<.05).
Introduction
oxoplasmosis is a protozoan parasitic infection that has a worldwide distribution. Toxoplasma gondii (T. gondii) causes toxoplasmosis, that is, an obligate intracellular protozoan. T. gondii infects most of the warm-blooded vertebrates, for example, humans, other mammals and birds (1) . Seroepidemiological studies show that T. gondii antibodies are in serum of one-third of the world adult population (2) . Prevalence rates are different in terms of the location and due to differences of culture and health information. Studies show that the toxoplasmosis prevalence rate is 16-40% in North America and Britain, as well as in Central and South America and Europe, it is estimated to be 80-50% (3, 4) . Toxoplasmosis occurs mostly in tropical and subtropical areas. T. gondii requires 2 hosts to complete its life cycle including the family of cats as the definitive host and vertebrates such as birds and T Forough Kazemi 1, 2 , Somayeh Fallahizadeh* 1,2 13 mammals as an intermediate host. The main routes of transmission include the consumption of water contaminated with oocytes, raw or undercooked meat containing tissue cysts, as well as congenital transmission (5) . Individuals of at high risk for toxoplasmosis are immunocompromised persons. Studies have also shown that the infection is related to nervous system disorders such as epilepsy, bipolar disorder and schizophrenia (6) . Symptoms in individuals with healthy immune system are mild and transient that include mild fever and swollen lymph glands. In individuals with immune system dysfunction and hemodialysis, latent form of the parasite can be reactivated causing different clinical complicacies from swelling of lymph, damage to the central nervous system, epilepsy, cerebral calcifications, pneumonia and myocarditis (7) . Because of the immunodeficiency in hemodialysis patients, these individuals may be at higher risk for reactivating chronic toxoplasmosis. Therefore, an early and definite diagnosis of and definitive in these individuals is highly advisable (8) . Since hemodialysis patients are at higher risk for infection of T. gondii; thus, the aim of this study is to investigate seroepidemiological aspect of toxoplasmosis in hemodialysis patients of Ahvaz, southwest of Iran in 2015-2016.
Methods

Study area
Ahvaz is a city in the center of Khuzestan Province in Southwest of Iran. The city is 375 kilometers square and its population has been reported as 1,425,891 until 2006. The city has a desert like climate with temperatures above 50° C that is one of the hot cities in the world. The average annual rainfall is about 230 mm. According to the recent report by the World Health Organization (WHO), Ahvaz has the most polluted climate in the world.
Study population
This is a cross-sectional study. A total of 160 participants, 80 hemodialysis patients (test group) and 80 healthy persons (control group) referred to hospitals of Jundishapure University of Medical Sciences (southwest of Iran) were selected randomly. Informed consent was obtained from all participants included in the study (9) .
Sampling collection and Serological diagnosis
Five ml blood samples taken from hemodialysis patients as well as healthy subjects were centrifuged. Then, 2 ml of isolated serum was placed in microtube and was maintained until the time of testing at 20 °C. To test the samples, they were taken out of the freezer and were melted. Anti-Toxoplasma IgG and IgM antibodies were measured by CLIA (Chemiluminescence) and ELISA (Enzyme-linked immunosorbent assay) tests (10) . For Measurement of IgG and IgM by chemiluminescence Architect Kit was used. In ELISA method, IgM and IgG were measured by Ab Capture ELISA and Indirect ELISA methods, respectively.
Ethical consideration
Before performing the research, it was explained to the participants. An informed consent was obtained from all participants included in the study.
Statistical analysis
To analyze the data from Chi-square tests and SPSS, statistical software of version 21 was used. The Pvalue less than 0.05 was considered significant. Tables 1 and 2 show IgG antibody of T. gondii by ELISA and CLIA in hemodialysis patients and healthy subjects, respectively: For the antibody of IgG, in hemodialysis patients were positive, that is, 35 (43.8%) and 25 (31.3%) by ELISA and CLIA respectively. In healthy individuals a positive result of 22 (27.5%) and 13 (16.3%) by ELISA and CLIA, was obtained respectively. The IgG antibody in hemodialysis patients was significantly higher than healthy subjects in both methods ELISA and CLIA (P<0.05).
Results
Also, tables 3 and 4 show IgM antibody of T. gondii by ELISA and CLIA in hemodialysis patients and healthy subjects, respectively. Antibody of IgM, in hemodialysis patients showed positive data of 5 (6.3%) by ELISA and 4 (5%) by CLIA and in healthy individuals a positive of 4 (5%) was obtained by showed that the prevalence of T. gondii was significant difference between the two groups of control (n = 120) and hemodialysis (n = 135) and this parasite was greater in hemodialysis patients. So that was a positive for 63% hemodialysis patients and 33.3% of healthy individuals (14) . (17) . The results of all these studies indicate that the prevalence of T. gondii in patients undergoing hemodialysis is higher than healthy subjects. The patients due to weakened immunity may activate latent form of toxoplasmosis, which is followed by a lot of complications caused by infection with T. gondii. Thus, the results of this research can be a help in planning to control and prevent the parasite in hemodialysis patients. One of the strengths of this study is using two powerful diagnostic tests for IgM and IgG antibodies but the limitation of this study is the low sample size. So, it is suggested to the succeeding researchers to go through the tests using samples with high volumes.
Conclusion
The prevalence of Toxoplasma in hemodialysis patients has been higher than healthy subjects. Because of immunodeficiency in hemodialysis patients, latent form of the parasite can be reactivated causing different clinical complicacies such as swelling of lymph nodes, damage to the central nervous system (e.g., epilepsy or cerebral calcification), pneumonia and myocarditis. Our findings show a relatively high prevalence of the parasite among hemodialysis patients and healthy individuals in Ahvaz. So, the health authorities of Ahvaz city must pay more attention to control of the infection, especially in hemodialysis patients.
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